Cancer prevention in humans at high-risk for development of cancer: Prevention of oral dysplasia in humans by berry formulations

Berries and Cancer Prevention

Volumn , Issue , 2011, Pages 247-258

  Mallery, Susan R ^a   Tong, Meng ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Indicators of therapeutic efficacy; Local delivery formulations; Oral dysplasia chemopreventive trials; Oral epithelial dysplasia

Indexed keywords

EID: 84857679616     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-7554-6_13     Document Type: Chapter

References (61)

1. Arduino PG, Surace A, Carbone M et al (2009) Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med 38:540-544
2. Bagan J, Sarrion G, Jimenez Y (2010) Oral cancer: clinical features. Oral Oncol. doi:10.1016/j.oraloncology.2010.03.009
3. Brennan M, Migliorati CA, Lockhart PB et al (2007) Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(S19):e1-e12
4. Chan G, Boyle JO, Yang EK et al (1999) Cyclooxgenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59:991-994
5. Chen YJ, Chang JT, Liao CT et al (2008) Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 99:1507-1514
6. Chen T, Hwang H, Rose ME et al (2006a) Chemopreventive properties of black raspberries in N-Nitrosomethylbenzylamine-Induced rat esophageal tumorigenesis: down-regulation of Cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res 66:2853-2859
7. Chen T, Rose ME, Hwang H et al (2006b) Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis. 27:2301-2307
8. Chiesa F, Tradati N, Gregolato R et al (2005) Randomized trial of fenretinide (4-HPR) to prevent recurrences, new lacalizations, and carcinomas in patients operated on for oral leukoplakia: Long term results. Int J Cancer 115:625-629
9. Connelly ST, Macabeo-Ong M, Dekker N et al (2005) Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol 41:261-267
10. Epstein JB, Gorsky M (1999) Topical application of vitamin A to oral leukoplakia. Cancer 86: 921-927
11. Fleschhut J, Kratzer F, Rechkemmer G et al (2006) Stability and biotranformation of various anthocyanins in vitro. Eur J Nutr 45:7-18
12. Freemantle SJ, Spinella MJ, Dmitrovsky E (2003) Retinoids in cancer therapy and chemopreven-tion: promise meets resistance. Oncogene 22:7305-7315
13. Gallo O, Masini E, Bianchi B et al (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33:708-714
14. Gao S, Worm J, Guldberg P et al (2004) Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma. Br J Cancer 91:760-764
15. Garewal HS, Katz RV, Meyshens F et al (1999) B-carotene produces sustained remissions in patients with oral leukoplakia results of a multicenter prospective trial. Arch Otolaryngol Head Neck Surg 125:1305-1310
16. Garewal HS, Meyskens FLJ, Killen D et al (1990) Response of oral leukoplakia to beta-carotene. J Clin Oncol 8:1715-1720
17. Gillison ML, Souza GD, Westra W et al (2008) Distinct risk factor profiles for human papillo-mavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407-420
18. Goon PK, Stanley MA, Ebmeyer J et al (2009) HPV & head and neck cancer: a descriptive update. Head Neck Oncol 1:36
19. Greer RO (2006) Pathology of malignant and premalignant oral epithelial lesions. Otolaryngol Clin North Am 39:249-275
20. Hail N Jr, Kim HJ, Lotan R (2006) Mechanisms of fenretinide-induced apoptosis. Apoptosis 11:1677-1694
21. Hecht SS, Huang C, Stoner GD et al (2006) Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7, 8-diol-epoxide induced NFκB and AP-1 activity. Carcinogenesis 27:1617-1626
22. Hong WK, Endicott J, Itri LM et al (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-1505
23. Huang C, Huang Y, Hu W et al (2002) Inhibition of benzo(a)pyrene diol-epoxide-induced trans-activation of activated protein 1 and nuclear factor κB by black raspberry extracts. Cancer Res 62:6857-6863
24. Huang C, Li J, Song L, Zhang D et al (2006) Black raspberry extracts inhibit Benzo(a)Pyrene Diol-Epoxide-induced activator Protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-Kinase/Akt pathway. Cancer Res 66:581-587
25. Islam MN, Kornberg L, Veenker E, et al (2010) Anatomic site based ploidy analysis of oral premalignant lesions. Head Neck Pathol 4:10-14
26. Johnson N (2001) Tobacco use and oral cancer: a global perspective. J Dent Educ 65:328-339
27. Kramer IR, Lucas RB, Pindborg JJ et al (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518-539
28. Kresty LA, Morse MA, Morgan C et al (2001) Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61:6112-6119
29. Li Y, Li L-J, Zhang S-T, Wang L-J et al (2009) In vitro and clinical studies of gene therapy with recombinant human Adenovirus-p53 inject for oral leukoplakia. Clin Cancer Res 15:6724-6731
30. Lippman SM, Batsakis JG, Toth BB et al (1993) Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328:15-20
31. Lippman SM, Lee JJ, Martin JW et al (2006) Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res 12:3109-3114
32. Mallery SR, Stoner GD, Larsen PE et al (2007) Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention. Pharm Res 24:728-737
33. Mallery SR, Zwick JC, Pei P et al (2008) Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res 68:4945-4957
34. Mehanna HM, Rattay T, Smith J et al (2009) Treatment and follow-up of oral dysplasia-a systematic review and meta-analysis. Head Neck 31:1600-1609
35. Mulshine JL, Atkinson JC, Greer RO et al (2004) Randomized, double-blind, placebo-controlled phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res 10:1565-1573
36. Neville BW, Damm DD, Allen CM et al (2009) Epithelial pathology. In: Oral and maxillofacial pathology, 3rd edn. Sauders Elsevier, St. Louis
37. Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52:195-215
38. Papadimitrakopoulou VA, Hong WK (2000) Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer. Int J Cancer. 88:852-855
39. Papadimitrakopoulou VA, William WN, Dannnberg AJ et al (2008) Randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res 14:2095-2101
40. Prior RL, Wu X (2006) Anthocyanins: Structural characteristics that result in unique metabolic patterns and biological activities. Free Rad Res 40:1014-1028
41. Reichart PA, Philipsen HP (2005) Oral erythroplakia-a review. Oral Oncol. 41:551-561
42. Richie JP Jr, Kleinman W, Marina P et al (2008) Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer 60:474-482
43. Rodgrigo KA, Rawal Y, Renner RJ et al (2006) Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutrition And Cancer 54:58-68
44. Rodriguez T, Altieri A, Chatenoud L et al (2004) Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 40:207-213
45. Rudin CM, Cohen EE, Papadimitrakopoulou VA et al (2003) An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol 21:4546-4552
46. Scuibba JJ (1995) Oral leukoplakia. Crit Rev Oral Biol Med 6:147-160
47. Scully C, Bagan J (2009) Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 15:388-399
48. Shah JP, Strong EW, DeCosse JJ et al (1983) Effect of retinoids on oral leukoplakia. Am J Surg 146:466-470
49. Shumway BS, Kresty LA, Larsen PE et al (2008) Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin Cancer Res 14: 2421-2430
50. Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53:563-568
51. Smith W, Saba N (2005) Retinoids as chemoprevention for head and neck cancer: where do we go from here? Crit Rev Oncol Hematol 55:143-152
52. Sood S, Shiff SJ, Yang CS et al (2005) Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention. Oral Oncol 41:562-567
53. Tian Q, Gusti MM, Stoner GD et al (2006) Urinary excretion of black raspberry (Rubus occidentalis) anthocyanins and their metabolism. J Agric Food Chem 54:1467-1472
54. Tsao AS, Liu D, Martin J et al (2009) Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res 2:931-941
55. Ugalde CM, Liu Z, Ren C et al (2009) Distribution of anthocyanins delivered from a bioadhe-sive black raspberry gel following topical application in normal healthy volunteers. Pharm Res 26:977-986
56. Vigneswaran N, Tilashalski K, Rodu B et al (1995) Tobacco use and cancer. A reappraisal. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80:178-182
57. Waldron CA, Shafer WG (1975) Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer 36:1386-1392
58. Walle T, Browning AM, Steed LL et al (2005) Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity. J Nutr 135:48-52
59. Wang L-S, Hecht SS, Carmella SG et al (2009) Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res 2:84-93
60. William WN Jr, Lee J, Lippman SM et al (2009) High-dose fenretinide in oral leukoplakia. Cancer Prev Res 2:22-26
61. Xue H, Aziz RM, Sun N et al (2001) Inhibition of cellular transformation by berry extracts. Carcinogenesis 22:351-356